ClinicalTrials.gg
RecruitingNCT04118712OTBUpdated Sep 3, 2026

Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age

An observational study in Benign Cysts Ovarian, Cystectomy and Torsion, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Recruiting at 1 site in United States. Open to female participants aged Up to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago · Observational

From the registry’s dates

  • Started Oct 2016; still recruiting 10 years later.
Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
100
Ages
Up to 18 Years
Sex
Female
01

Study summary

A child is eligible to participate in this study because she is having surgery on her ovary. The investigators may obtain a sample of any discarded tissue from the surgery for an ovarian tissue library. This study is being conducted to understand how common ovarian conditions effect the number and quality of ovarian follicles and the reproductive potential of the ovary.

Read the detailed description

The investigators intend to enroll 100 girls and women in this study who are undergoing surgery involving the ovary. This may include patients with different conditions for comparison, such as ovarian cysts or masses and ovarian torsion. For each patient, the investigators will obtain the discarded tissue from the operating room after the affected ovarian tissue is resected. The tissue sample will only be taken for the tissue library from ovarian tissue that would otherwise be discarded.

No additional tissue will be collected other than that which is already removed as part of the ovarian procedure. No additional surgery or other procedures will be performed for the purposes of this study. The tissue will be assigned a study ID number and the age, gender and diagnosis of the child will be entered on the tissue library log and maintained for the duration of the study.

02

Conditions studied

  • Benign Cysts Ovarian
  • Cystectomy
  • Torsion
  • Malignant Cysts Ovarian

Browse trials for

03

In context

Ovarian Cysts

80 studies on the registry are indexed under Ovarian Cysts; 16 are open to participants now.

This study's planned enrollment of 100 is below the median of 200 across 27 observational studies indexed under Ovarian Cysts.

Browse Ovarian Cysts studies →

Lead sponsor

Ann & Robert H Lurie Children's Hospital of Chicago is the lead sponsor of 180 studies on the registry; 28 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patient recruitment could occur in either the pediatric surgery outpatient clinic or during hospital admission depending on the underlying condition and urgency of the procedure.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pre and Post Pubertal females
  • Ages 0-18 years old
  • Undergoing scheduled or emergent operative procedures involving the ovary

    1. oophorectomy (torsion, benign mass/cyst, malignant mass/cyst)
    2. ovarian cystectomy

Exclusion criteria

Exclusion Criteria:

  • Pregnant females
05

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
100 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Ovarian Tissue Banking

    The primary purpose of this study is analyzing the histologically ovarian tissue obtained surgically due to different ovarian pathologies. The tissue will be stained and follicles of varying stages will be counted and compared for different patient ages and ovarian pathologies. The extra-cellular matrix will also be stained and compared between different patient ages and ovarian pathologies.

    Time frame: October 2016- December 2030

07

Study locations

1 of 1 sites recruiting
  • Ann & Robert H Lurie Childrens Hospital
    Chicago, Illinois 60611, United States
    Recruiting
    • Jacqueline Searcy · Contact
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2016 (actual). Primary completion is estimated for Dec 2030, 170 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 4, 2019
First posted
Oct 8, 2019
StartActual
Oct 18, 2016
Primary completionEst.
Dec 2030
CompletionEst.
Dec 2030
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04118712
Responsible party
Erin Rowell (MD, Ann & Robert H Lurie Children's Hospital of Chicago) — Principal investigator
First posted
Oct 8, 2019
Start date
Oct 18, 2016
Primary completion
Dec 2030 (estimated)
Completion
Dec 2030 (estimated)
Last update
Sep 3, 2026

Study contacts

Jacqueline Searcy
Contact
FertilityPreservationMB@luriechildrens.org
312-227 ext. 4758
Erin Rowell, MD
study director · Ann & Robert H Lurie Children's Hospital of Chicago

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion